Related Experiment Videos

Tourette syndrome. The pediatric perspective

Insights

Tourette syndrome in children often begins around age 6 with tics and vocalizations. Early diagnosis and haloperidol treatment show significant improvement in most pediatric patients.

Area of Science:

  • Neurology
  • Pediatrics
  • Child Psychiatry

Background:

  • Tourette syndrome is a complex neurological disorder affecting children.
  • Characterized by involuntary motor and vocal tics.
  • Diagnosis can be delayed, impacting management.

Purpose of the Study:

  • To detail the clinical presentation of Tourette syndrome in a pediatric cohort.
  • To investigate diagnostic delays and treatment outcomes.
  • To explore associated neurological and academic factors.

Main Methods:

  • Clinical case series of 15 children diagnosed with Tourette syndrome.
  • Retrospective review of medical histories and examination findings.
  • Assessment of treatment response to haloperidol.

Main Results:

  • Typical onset around age 6 with initial symptoms like eyeblinking.
  • Development of diverse tics and vocalizations, with infrequent coprolalia/echolalia.
  • Average diagnostic delay of four years.
  • Haloperidol treatment yielded good to excellent response in 75% of patients.
  • Associated factors include encephalopathic events, "soft" neurological signs, and school difficulties.
  • Personal and social adjustments were generally positive.

Conclusions:

  • Tourette syndrome in children presents with specific early symptoms and diagnostic challenges.
  • Haloperidol is an effective treatment option for pediatric Tourette syndrome.
  • Despite associated issues, affected children often achieve good social and personal adjustment.

Related Concept Videos